心血管疾病中的免疫与炎症。
Immunity and inflammation in cardiovascular disorders.
机构信息
University of Manchester, Manchester, UK.
Escuela Naval Militar (E.N.M.), Pontevedra, Spain.
出版信息
BMC Cardiovasc Disord. 2023 Mar 23;23(1):148. doi: 10.1186/s12872-023-03185-z.
Abstract
Recent studies have developed our understanding of the role of the immune system and inflammation in Cardiovascular Disease (CVD), opening new avenues for risk stratification and therapeutic intervention. However, gaps in our knowledge remain. To address this issue, BMC Cardiovascular Disorders has launched a Collection on "Immunity and Inflammation in Cardiovascular Disorders".
摘要
最近的研究加深了我们对免疫系统和炎症在心血管疾病（CVD）中的作用的理解，为风险分层和治疗干预开辟了新的途径。然而，我们的知识仍然存在空白。为了解决这个问题，BMC 心血管疾病推出了一个关于“心血管疾病中的免疫和炎症”的专刊。
相似文献
1
Immunity and inflammation in cardiovascular disorders.心血管疾病中的免疫与炎症。
BMC Cardiovasc Disord. 2023 Mar 23;23(1):148. doi: 10.1186/s12872-023-03185-z.
2
Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.抑郁症和心血管疾病中针对炎症的当前治疗方法
Curr Drug Metab. 2018;19(8):674-687. doi: 10.2174/1389200219666180305143501.
3
Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation.基于蛋白质组学的上下文丰富的互作组有助于鉴定巨噬细胞激活的新型调控因子。
Elife. 2018 Oct 10;7:e37059. doi: 10.7554/eLife.37059.
4
Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.HIV 与非 HIV 受试者的免疫激活模式及其与心血管疾病风险的关系。
Front Immunol. 2021 Jul 5;12:647805. doi: 10.3389/fimmu.2021.647805. eCollection 2021.
5
The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.矿物质皮质激素受体在心血管疾病免疫细胞中的作用。
Br J Pharmacol. 2022 Jul;179(13):3135-3151. doi: 10.1111/bph.15782. Epub 2022 Feb 15.
6
Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?心血管疾病中的血管炎症：免疫系统是保护还是旁观者？
Curr Pharm Des. 2021;27(18):2141-2150. doi: 10.2174/1381612827666210118121952.
7
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.靶向 NLRP3（核苷酸结合域、富含亮氨酸重复序列、含pyrin 结构域蛋白 3）炎症小体治疗心血管疾病。
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2765-2779. doi: 10.1161/ATVBAHA.118.311916.
8
Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease?Toll样受体调节：心血管疾病中的一种新型治疗策略？
Expert Opin Ther Targets. 2008 Nov;12(11):1329-46. doi: 10.1517/14728222.12.11.1329.
9
Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets.炎症相关心血管疾病：从分子机制到治疗靶点。
Curr Pharm Des. 2020;26(22):2565-2573. doi: 10.2174/1381612826666200213123029.
10
Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.慢性肾脏病中的心血管生物标志物：病理生理学及其对心脏病临床管理的意义
Am J Kidney Dis. 2006 Sep;48(3):341-60. doi: 10.1053/j.ajkd.2006.06.005.
引用本文的文献
1
The association between neutrophil percentage-to-albumin ratio and cardiovascular disease: evidence from a cross-sectional study.中性粒细胞与白蛋白比值和心血管疾病之间的关联：一项横断面研究的证据。
Front Cardiovasc Med. 2025 May 14;12:1557507. doi: 10.3389/fcvm.2025.1557507. eCollection 2025.
2
Proteomic profiling reveals a higher presence of glycolytic enzymes in human atherosclerotic lesions with unfavourable histological characteristics.蛋白质组学分析显示，在具有不良组织学特征的人类动脉粥样硬化病变中，糖酵解酶的含量更高。
Cardiovasc Res. 2025 Jul 31;121(8):1187-1203. doi: 10.1093/cvr/cvaf077.
3
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology.中药复方通过调节信号通路改善心脏相关病理状况。
Front Pharmacol. 2025 Apr 2;16:1499060. doi: 10.3389/fphar.2025.1499060. eCollection 2025.
4
Infectious diseases, cardio-cerebrovascular health and vaccines: pathways to prevention.传染病、心脑血管健康与疫苗：预防途径
Aging Clin Exp Res. 2025 Mar 13;37(1):80. doi: 10.1007/s40520-025-02968-y.
5
Lymphocyte Subset Imbalance in Cardiometabolic Diseases: Are T Cells the Missing Link?心血管代谢疾病中的淋巴细胞亚群失衡：T细胞是缺失的环节吗？
Int J Mol Sci. 2025 Jan 21;26(3):868. doi: 10.3390/ijms26030868.
6
Definition of clinical immunology around the globe.全球临床免疫学的定义。
Front Immunol. 2025 Jan 28;16:1483391. doi: 10.3389/fimmu.2025.1483391. eCollection 2025.
7
Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases.革新心血管研究：类器官作为理解和治疗心血管疾病的希望之光。
Mater Today Bio. 2024 Dec 9;30:101396. doi: 10.1016/j.mtbio.2024.101396. eCollection 2025 Feb.
8
Pericytes and Extracellular Vesicle Interactions in Neurovascular Adaptation to Chronic Arterial Hypertension.周细胞与细胞外囊泡在神经血管对慢性动脉高血压适应过程中的相互作用
J Am Heart Assoc. 2025 Jan 7;14(1):e038457. doi: 10.1161/JAHA.124.038457. Epub 2024 Dec 24.
9
REDD1 Deletion Suppresses NF-κB Signaling in Cardiomyocytes and Prevents Deficits in Cardiac Function in Diabetic Mice.REDD1 缺失可抑制心肌细胞中的 NF-κB 信号通路并防止糖尿病小鼠的心脏功能障碍。
Int J Mol Sci. 2024 Jun 12;25(12):6461. doi: 10.3390/ijms25126461.
10
The Emerging Specialty of Cardio-Rheumatology.心血管风湿病学：新兴亚专科
Curr Atheroscler Rep. 2024 Sep;26(9):499-509. doi: 10.1007/s11883-024-01221-7. Epub 2024 Jun 24.
本文引用的文献
1
Clinical approach to the inflammatory etiology of cardiovascular diseases.心血管疾病炎症病因的临床研究方法
Pharmacol Res. 2020 Sep;159:104916. doi: 10.1016/j.phrs.2020.104916. Epub 2020 May 20.
2
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
3
Clonal hematopoiesis in human aging and disease.人类衰老和疾病中的克隆性造血
Science. 2019 Nov 1;366(6465). doi: 10.1126/science.aan4673.
4
Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?炎症性肠病与心血管疾病风险：所有炎症都会导致心脏病吗？
Trends Cardiovasc Med. 2020 Nov;30(8):463-469. doi: 10.1016/j.tcm.2019.10.001. Epub 2019 Oct 11.
5
Immunity and Inflammation in Atherosclerosis.动脉粥样硬化中的免疫与炎症。
Circ Res. 2019 Jan 18;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591.
6
Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies.自身免疫性和炎性心脏离子通道病新出现的心律失常风险
J Am Heart Assoc. 2018 Nov 20;7(22):e010595. doi: 10.1161/JAHA.118.010595.
7
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.低剂量甲氨蝶呤预防动脉粥样硬化事件。
N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.
8
Incretin drugs as modulators of atherosclerosis.肠促胰岛素类药物作为动脉粥样硬化的调节剂。
Atherosclerosis. 2018 Nov;278:29-38. doi: 10.1016/j.atherosclerosis.2018.09.011. Epub 2018 Sep 14.
9
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
10
Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.单核细胞/巨噬细胞衍生的胰岛素样生长因子-1协调小鼠骨骼肌再生并调节自分泌极化。
Mol Ther. 2015 Jul;23(7):1189-1200. doi: 10.1038/mt.2015.66. Epub 2015 Apr 21.
Zotero 插件